Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Instruments (Peptide Synthesizer, Chromatography, Lyophilizer), Technique (Solid-phase, Solution-phase, Hybrid), Services, Application (Therapeutics), End User - Global Forecast to 2029
세계의 펩타이드 합성 시장 규모는 2024년 8억 1,000만 달러로 평가되었습니다. 2024년부터 2029년까지 연평균 복합 성장률(CAGR) 11.7%로 추이하고, 2029년에는 14억 1,000만 달러 이상 규모로 성장할 것으로 예측되고 있습니다.
펩타이드 합성 시장은 기술의 진보, 창약 연구 증가, 맞춤형 의료에 대한 수요 증가 등 여러 요인에 의해 견인되고 있습니다. 게다가 암과 당뇨병과 같은 만성 질환의 유병률 증가는 표적 치료에서 치료 펩타이드 수요를 추진하고 시장 성장을 더욱 촉진하고 있습니다.
| 조사 범위 |
| 조사 대상 연도 |
2022-2029년 |
| 기준 연도 |
2023년 |
| 예측 기간 |
2024-2029년 |
| 단위 |
금액(달러) |
| 부문 |
제공, 제품, 소모품, 기기, 서비스, 용도, 기술, 최종 사용자 |
| 대상 지역 |
북미, 유럽, 아시아태평양, 라틴아메리카, 중동&아프리카 |
"시약 부문에서는 수지·아미노산이 압도적 점유율을 차지한다"
수지는 고상 펩타이드 합성(SPPS)의 기초를 형성하고 펩티드 사슬을 단계적으로 구축하기위한 안정적인 플랫폼 역할을 합니다. 프리로드 수지 및 특수 링커와 같은 수지의 발전은 시장에 긍정적인 영향을 미칠 전망입니다.
"펩타이드 합성 서비스가 시장을 선도"
서비스별로는 창약, 치료 개발, 연구 용도로 필요한 커스텀 펩티드나 복잡한 펩티드 수요 증가에 대응할 수 있기 때문에 펩타이드 합성 서비스의 부문이 시장을 선도했습니다. 또한 맞춤형 의료 및 펩티드 기반 백신의 상승이 맞춤 합성 수요를 높이고 이 부문의 성장을 이끌고 있습니다.
"용도별로는 치료제 부문이 2023년 시장을 선도"
고상 펩타이드 합성(SPPS)이나 재조합 DNA법 등의 펩타이드 합성 기술의 개발에 의해 백신 개발용 고순도로 비용 효율적인 펩티드의 효율적인 생산이 가능해지고 있습니다. 개인화된 면역요법에 대한 관심 증가와 펩티드 기반 백신 연구에 대한 투자 증가는 시장에서 주도적 지위를 더욱 견고하게 만들고 있습니다.
"북미 : 펩타이드 합성 시장에서 최대 점유율"
북미는 2023년 시장을 선도했으며 예측 기간 동안에도 유사한 리드를 보여줄 것으로 예상됩니다. 미국은 주요 사업자의 강력한 존재에 견인되어 바이오 의료 연구 및 펩티드 기반 치료제의 기술 혁신에 상당한 자금을 제공합니다. 또한 유럽은 독일과 영국과 같은 국가들이 크게 기여하고 있으며 시장에서 큰 점유율을 보여줍니다. 이러한 이점은 강력한 R&D 활동, 학술기관과 산업계의 협업, 개인화된 의료 및 펩티드 기반 의약품에 대한 관심 증가에 기인합니다.
본 보고서에서는 세계 펩타이드 합성 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 기술·특허 동향, 법규제 환경, 사례 연구, 시장 규모 추이와 예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 서론
제2장 조사 방법
제3장 주요 요약
제4장 중요 인사이트
제5장 시장 개요
- 시장 역학
- 고객의 사업에 영향을 주는 동향/혁신
- 가격 분석
- 공급망 분석
- 밸류체인 분석
- 생태계 분석
- 투자와 자금조달 시나리오
- 기술 분석
- 특허 분석
- 무역 분석
- 주요 회의 및 이벤트
- 규제 상황
- Porter's Five Forces 분석
- 주요 이해관계자와 구매 기준
- AI/생성형 AI가 펩타이드 합성 시장에 미치는 영향
제6장 펩타이드 합성 시장 : 제공별
제7장 펩타이드 합성 제품 시장 : 유형별
- 소모품
- 기기
- 펩타이드 합성기
- 크로마토그래피 시스템
- 라이오필라이저
- 기타
제8장 펩타이드 합성 서비스 시장 : 유형별
- 펩타이드 합성
- 펩티드 정제 서비스
- 펩티드 라이브러리 합성
- 펩티드 분석 서비스
제9장 펩타이드 합성 시장 : 기술별
제10장 펩타이드 합성 시장 : 용도별
제11장 펩타이드 합성 제품 시장 : 최종 사용자별
- 제약·바이오 의약품 기업
- CRO·CMO
- 학술연구기관
- 의료기기 기업
- 병원과 진단센터
제12장 펩타이드 합성 서비스 시장 : 최종 사용자별
- 제약·바이오 의약품 기업
- 의료기기 기업
- 병원과 진단센터
- 학술연구기관
- CRO·CMO
제13장 펩타이드 합성 시장 : 지역별
- 북미
- 유럽
- 거시경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타
- 아시아태평양
- 거시경제 전망
- 중국
- 일본
- 인도
- 한국
- 호주
- 기타
- 라틴아메리카
- 중동
- 아프리카
제14장 경쟁 구도
- 개요
- 주요 진입기업의 전략/강점
- 수익 분석
- 시장 점유율 분석
- 기업이치평가와 재무지표
- 브랜드/제품 비교
- 기업 평가 매트릭스 : 주요 기업
- 기업평가 매트릭스 : 스타트업/중소기업
- 경쟁 시나리오
제15장 기업 프로파일
- 주요 기업
- THERMO FISHER SCIENTIFIC INC.
- MERCK KGAA
- AGILENT TECHNOLOGIES, INC.
- GENSCRIPT
- KANEKA CORPORATION
- BACHEM
- SYNGENE INTERNATIONAL LIMITED
- MESA LABS, INC.
- BIOTAGE
- CEM CORPORATION
- DALTON PHARMA SERVICES
- BIO-SYNTHESIS INC.
- CSBIO
- PROTEOGENIX
- INNOVAGEN AB
- BIOSYNTH
- 기타 기업
- AURIGENE PHARMACEUTICAL SERVICES LTD.
- CORDENPHARMA
- JPT PEPTIDE TECHNOLOGIES
- PUROLITE
- BIOMATIK
- CPC SCIENTIFIC INC.
- ADVANCED CHEMTECH, INC.
- AMBIOPHARM INC.
- LUXEMBOURG BIO TECHNOLOGIES
- AAPPTEC
- ANYGEN
- CHEMPEP
- PROTEOGENIX
제16장 부록
KTH
The global peptide synthesis market is projected to surpass USD 1.41 billion in 2029 from USD 0.81 billion in 2024, with a significant CAGR of 11.7%. The peptide synthesis market is driven by several factors such as advancements in technology, increasing research in drug discovery, and the growing demand for personalized medicine. Additionally, the rising prevalence of chronic diseases such as cancer and diabetes is fueling demand for therapeutic peptides in targeted therapies further propelling the growth of the market.
| Scope of the Report |
|---|
| Years Considered for the Study | 2022-2029 |
| Base Year | 2023 |
| Forecast Period | 2024-2029 |
| Units Considered | Value (USD) |
| Segments | Offerings, Products, Consumables, Instruments, Services, Applications, Technique and End User |
| Regions covered | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
"Resins and Amino acids accounted for the dominant share in the reagents market"
Based on offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Resins form the foundation of solid-phase peptide synthesis (SPPS), serving as a stable platform for the stepwise construction of peptide chains. Advancements in resins such as preloaded resins and specialized linkers are likely to impact positively on the market.
"Peptide synthesis services dominated the market"
The services segment is further segmented into peptide library synthesis, peptide synthesis, peptide purification services, and peptide analysis services. Peptide synthesis services dominated the market due to their ability to meet the increasing demand for custom and complex peptides required in drug discovery, therapeutic development, and research applications. Additionally, the rise of personalized medicine and peptide-based vaccines has increased the demand for custom synthesis driving the segmental growth.
"Therapeutics segment dominated the application segment in 2023"
Applications segment is divided into Therapeutics, Diagnostics and Research & Development. Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules). Advancements in peptide synthesis technologies, such as solid-phase peptide synthesis (SPPS) and recombinant DNA methods, has enabled the efficient production of high-purity, cost-effective peptides for vaccine development. The growing focus on personalized immunotherapies and increased investment in peptide-based vaccine research further reinforce their leading position in the market.
"North America: the largest share of the peptide synthesis market"
The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the peptide synthesis market in 2023 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the strong presence of key players like Thermo Fisher Scientific and CEM Corporation, with substantial funding for biomedical research and innovation in peptide-based therapeutics. Europe holds a significant share of the market, with countries like Germany, and UK being major contributors. This dominance attributed to strong R&D activities, collaborations between academic institutions and industry, and a growing focus on personalized medicine and peptide-based drugs.
In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the peptide synthesis market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Tier 1- 45%, Tier 2- 35%, Tier 3- 20%
- By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%
Bachem Holding AG (Switzerland), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), GenScript (China), and CEM Corporation (US) are some of the major players operating in the peptide synthesis market.
Research Coverage:
This research report categorizes the peptide synthesis market offerings (products & services), products (Consumables and Instruments), consumables (Reagents and Other Consumables), Reagents (Resins, Amino Acids, Coupling Reagents, Dyes and Fluorescent Labelling Reagents, Deprotection Reagents, Cleavage Reagents and Other Reagents), Instruments (Peptide Synthesizers (automated and manual), Chromatography Equipment, Lyophilizers and Others). Services (Peptide Library Synthesis, Peptide Synthesis, Peptide Purification Services and Peptide Analysis Services), Technique (Chemical (Solid Phase Peptide Synthesis, Solution Phase peptide synthesis and Other Chemical Methods and Biological (Recombinant DNA Technology and Enzymes), Applications (Therapeutics, Diagnostics and Research & Development), Therapeutics by Indications (Cancer, Diabetes, Obesity, Autoimmune Disease and Other Disease Indication), Therapeutics by Molecules (Peptide-Based Vaccines, Peptide-Drug Conjugates (PDCs), Peptide Inhibitors and Other Molecules), End User (Pharmaceutical and biotechnology companies, CDMOs & CROs, Academic & Research Institutes, Medical Device Companies and Hospitals and Diagnostic Centers). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the peptide synthesis market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the peptide synthesis market.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the peptide synthesis and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (advancements in peptide therapeutics, technological advancements,
growing use of peptides in diagnostics and research), restraints (Regulatory Hurdles, High cost of peptide synthesis and instruments), opportunities (Adoption of personalized medicine, Rise in strategic collaborations and partnerships) and Challenges (Addressing Immunogenicity, Environmental Concerns) influencing the growth of the market.
- Product/Service Development/Innovation: Detailed insights on upcoming technologies in peptide synthesis manufacturing, research and development activities, and new product/service launches in the peptide synthesis market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the peptide synthesis market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc. and Merck KGaA (Germany), among others.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.3 STUDY SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 REGIONAL SCOPE
- 1.3.3 INCLUSIONS AND EXCLUSIONS
- 1.3.4 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY RESEARCH
- 2.1.2 PRIMARY RESEARCH
- 2.2 MARKET SIZE ESTIMATION METHODOLOGY
- 2.2.1 GLOBAL MARKET ESTIMATION
- 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
- 2.2.3 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH)
- 2.3 GROWTH RATE PROJECTIONS
- 2.4 DATA TRIANGULATION
- 2.5 RESEARCH ASSUMPTIONS
- 2.6 RESEARCH LIMITATIONS
- 2.7 RISK ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
- 4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT TYPE AND COUNTRY, 2023
- 4.3 PEPTIDE SYNTHESIS MARKET, BY OFFERING, 2024 VS. 2029
- 4.4 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW
- 5.1 INTRODUCTION
- 5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
- 5.2.1.1 Advancements in peptide therapeutics
- 5.2.1.2 Innovations in peptide synthesis instruments
- 5.2.1.3 Growing use of peptides in diagnostics and research
- 5.2.2 RESTRAINTS
- 5.2.2.1 Regulatory hurdles
- 5.2.2.2 High cost of peptide synthesis and instruments
- 5.2.3 OPPORTUNITIES
- 5.2.3.1 Adoption of personalized medicine
- 5.2.3.2 Strategic collaborations and partnerships
- 5.2.4 CHALLENGES
- 5.2.4.1 Immunogenicity issues
- 5.2.4.2 Environmental concerns
- 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 5.4 PRICING ANALYSIS
- 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
- 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION
- 5.5 SUPPLY CHAIN ANALYSIS
- 5.6 VALUE CHAIN ANALYSIS
- 5.7 ECOSYSTEM ANALYSIS
- 5.7.1 PEPTIDE SYNTHESIS MARKET: PRODUCT MANUFACTURERS
- 5.7.2 PEPTIDE SYNTHESIS MARKET: SERVICE PROVIDERS
- 5.7.3 PEPTIDE SYNTHESIS MARKET: END USERS
- 5.7.4 PEPTIDE SYNTHESIS MARKET: REGULATORY BODIES
- 5.8 INVESTMENT AND FUNDING SCENARIO
- 5.9 TECHNOLOGY ANALYSIS
- 5.9.1 KEY TECHNOLOGIES
- 5.9.1.1 Solid-phase peptide synthesis (SPPS)
- 5.9.1.2 Liquid-phase peptide synthesis (LPPS)
- 5.9.1.3 Enzymatic peptide synthesis
- 5.9.1.4 Continuous-flow peptide synthesis
- 5.9.2 COMPLEMENTARY TECHNOLOGIES
- 5.9.2.1 Labeling and tracking technologies
- 5.9.2.2 Purification techniques
- 5.9.3 ADJACENT TECHNOLOGIES
- 5.9.3.1 Cell-free protein synthesis
- 5.9.3.2 Protein design and engineering
- 5.10 PATENT ANALYSIS
- 5.11 TRADE ANALYSIS
- 5.11.1 TRADE DATA FOR HS CODE 902720 (CHROMATOGRAPHS AND ELECTROPHORESIS INSTRUMENTS)
- 5.11.1.1 Import data for HS code 902720
- 5.11.1.2 Export data for HS CODE 902720
- 5.11.2 TRADE DATA FOR HS CODE 841933 (LYOPHILISATION APPARATUS, FREEZE DRYING UNITS AND SPRAY DRYERS)
- 5.11.2.1 Import data for HS code 841993
- 5.11.2.2 Export data for HS code 841933
- 5.12 KEY CONFERENCES AND EVENTS, 2025-2026
- 5.13 REGULATORY LANDSCAPE
- 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.13.2 REGULATORY FRAMEWORK
- 5.13.2.1 North America
- 5.13.2.1.1 US
- 5.13.2.1.2 Canada
- 5.13.2.2 Europe
- 5.13.2.2.1 Germany
- 5.13.2.2.2 UK
- 5.13.2.2.3 France
- 5.13.2.3 Asia Pacific
- 5.13.2.3.1 Japan
- 5.13.2.3.2 China
- 5.13.2.4 Latin America
- 5.13.2.5 Middle East & Africa
- 5.13.2.5.1 GCC Countries
- 5.13.2.5.2 South Africa
- 5.14 PORTER'S FIVE FORCES ANALYSIS
- 5.14.1 BARGAINING POWER OF SUPPLIERS
- 5.14.2 BARGAINING POWER OF BUYERS
- 5.14.3 THREAT OF NEW ENTRANTS
- 5.14.4 THREAT OF SUBSTITUTES
- 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
- 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
- 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.15.2 BUYING CRITERIA
- 5.16 IMPACT OF AI/GENERATIVE AI ON PEPTIDE SYNTHESIS MARKET
- 5.16.1 INTRODUCTION
- 5.16.2 IMPACT OF AI ON PEPTIDE SYNTHESIS ECOSYSTEM
- 5.16.3 FUTURE OF GENERATIVE AI IN PEPTIDE SYNTHESIS ECOSYSTEM
6 PEPTIDE SYNTHESIS MARKET, BY OFFERING
- 6.1 INTRODUCTION
- 6.2 PRODUCTS
- 6.2.1 INCREASING ADOPTION OF SOLID AND LIQUID-PHASE PEPTIDE SYNTHESIS TO STIMULATE GROWTH
- 6.3 SERVICES
- 6.3.1 GROWING ADVANCEMENTS IN PEPTIDE DESIGN AND SYNTHESIS OPTIMIZATION TO FUEL MARKET
7 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY TYPE
- 7.1 INTRODUCTION
- 7.2 CONSUMABLES
- 7.2.1 REAGENTS
- 7.2.1.1 Resins
- 7.2.1.1.1 Growing demand for therapeutic peptides to boost market
- 7.2.1.2 Amino acids
- 7.2.1.2.1 Increasing advancements in synthetic amino acid modifications to aid growth
- 7.2.1.3 Coupling reagents
- 7.2.1.3.1 Rising adoption of high-throughput peptide synthesis to expedite growth
- 7.2.1.4 Dyes & fluorescent labeling reagents
- 7.2.1.4.1 Increasing demand for high-resolution, sensitive imaging technologies to promote growth
- 7.2.1.5 Deprotection reagents
- 7.2.1.5.1 Rising complexity of modified peptides and cyclic structures to facilitate growth
- 7.2.1.6 Cleavage reagents
- 7.2.1.6.1 Increasing use of complex peptides to sustain growth
- 7.2.1.7 Other reagents
- 7.2.2 OTHER CONSUMABLES
- 7.3 INSTRUMENTS
- 7.3.1 PEPTIDE SYNTHESIZERS
- 7.3.1.1 Automated peptide synthesizers
- 7.3.1.1.1 Increasing launches of automated peptide synthesizers to promote growth
- 7.3.1.2 Manual peptide synthesizers
- 7.3.1.2.1 Growing use of peptide synthesizers for early-stage drug discovery and research to fuel market
- 7.3.2 CHROMATOGRAPHY SYSTEMS
- 7.3.2.1 Increasing shift toward high-throughput and industrial-scale peptide production to amplify growth
- 7.3.3 LYOPHILIZERS
- 7.3.3.1 Rising influence of contract manufacturing organizations to encourage growth
- 7.3.4 OTHER INSTRUMENTS
8 PEPTIDE SYNTHESIS SERVICES MARKET, BY TYPE
- 8.1 INTRODUCTION
- 8.2 PEPTIDE SYNTHESIS
- 8.2.1 RISING ADOPTION OF PERSONALIZED MEDICINES AND TARGETED THERAPIES TO INTENSIFY GROWTH
- 8.3 PEPTIDE PURIFICATION SERVICES
- 8.3.1 GROWING EMPHASIS ON HIGH-QUALITY PEPTIDES IN PHARMACEUTICAL DEVELOPMENT AND BIOTECH TO DRIVE MARKET
- 8.4 PEPTIDE LIBRARY SYNTHESIS
- 8.4.1 INCREASING FOCUS ON SYNTHETIC BIOLOGY TO AUGMENT GROWTH
- 8.5 PEPTIDE ANALYSIS SERVICES
- 8.5.1 INCREASING ADVANCEMENTS IN MASS SPECTROMETRY AND CHROMATOGRAPHY TO BOLSTER GROWTH
9 PEPTIDE SYNTHESIS MARKET, BY TECHNIQUE
- 9.1 INTRODUCTION
- 9.2 CHEMICAL METHODS
- 9.2.1 SOLID-PHASE PEPTIDE SYNTHESIS
- 9.2.1.1 Increasing use of peptides and peptide derivatives in modern medicines use to encourage growth
- 9.2.2 LIQUID-PHASE PEPTIDE SYNTHESIS
- 9.2.2.1 Growing advancements in purification technologies to boost market
- 9.2.3 OTHER CHEMICAL METHODS
- 9.3 BIOLOGICAL METHODS
- 9.3.1 RECOMBINANT DNA TECHNOLOGY
- 9.3.1.1 Increasing innovations in genetic engineering and synthetic biology to drive market
- 9.3.2 ENZYMATIC SYNTHESIS
- 9.3.2.1 Growing shift toward sustainable and eco-friendly manufacturing to propel market
10 PEPTIDE SYNTHESIS MARKET, BY APPLICATION
- 10.1 INTRODUCTION
- 10.2 THERAPEUTIC APPLICATIONS
- 10.2.1 THERAPEUTIC APPLICATIONS, BY INDICATION
- 10.2.1.1 Cancer
- 10.2.1.1.1 Rising clinical trials to contribute to growth
- 10.2.1.2 Diabetes
- 10.2.1.2.1 Increasing need for diabetes management to favor growth
- 10.2.1.3 Obesity
- 10.2.1.3.1 Increasing development of next-generation weight management therapies to foster growth
- 10.2.1.4 Autoimmune diseases
- 10.2.1.4.1 Growing prevalence of rheumatoid arthritis, lupus, and multiple sclerosis to fuel market
- 10.2.1.5 Other diseases
- 10.2.2 THERAPEUTIC APPLICATIONS, BY MOLECULE
- 10.2.2.1 Peptide-based vaccines
- 10.2.2.1.1 Increasing research on infectious diseases and cancer immunotherapy to augment growth
- 10.2.2.2 Peptide-drug conjugates
- 10.2.2.2.1 Growing focus of pharmaceutical companies on drug conjugation to drive market
- 10.2.2.3 Peptide inhibitors
- 10.2.2.3.1 Rising traction for precision medicine to assist growth
- 10.2.2.4 Other molecules
- 10.3 DIAGNOSTIC APPLICATIONS
- 10.3.1 RISE OF PERSONALIZED MEDICINE AND POINT-OF-CARE TESTING TO ACCELERATE GROWTH
- 10.4 DISCOVERY & DEVELOPMENT APPLICATIONS
- 10.4.1 GROWING ADVANCEMENTS IN COMBINATORIAL CHEMISTRY AND HIGH-THROUGHPUT PEPTIDE LIBRARIES TO DRIVE MARKET
11 PEPTIDE SYNTHESIS PRODUCTS MARKET, BY END USER
- 11.1 INTRODUCTION
- 11.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 11.2.1 INCREASING RESEARCH ON GENOMICS AND MOLECULAR BIOLOGY TO EXPEDITE GROWTH
- 11.3 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
- 11.3.1 SHIFT TOWARD CUSTOM AND MODIFIED PEPTIDES TO DRIVE MARKET
- 11.4 ACADEMIC & RESEARCH INSTITUTES
- 11.4.1 INCREASING FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO SUPPORT GROWTH
- 11.5 MEDICAL DEVICE COMPANIES
- 11.5.1 BOOMING PEPTIDE-BASED DRUG DELIVERIES TO PROMOTE GROWTH
- 11.6 HOSPITALS & DIAGNOSTIC CENTERS
- 11.6.1 RISING DEMAND FOR PEPTIDE-BASED DIAGNOSTICS TO FAVOR GROWTH
12 PEPTIDE SYNTHESIS SERVICES MARKET, BY END USER
- 12.1 INTRODUCTION
- 12.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
- 12.2.1 INCREASING FOCUS ON PEPTIDE-BASED THERAPEUTICS IN ONCOLOGY AND METABOLIC DISORDERS TO INTENSIFY GROWTH
- 12.3 MEDICAL DEVICE COMPANIES
- 12.3.1 NEED TO DETECT INFECTIOUS DISEASES, CANCER, AND METABOLIC DISORDERS TO AID GROWTH
- 12.4 HOSPITALS & DIAGNOSTIC CENTERS
- 12.4.1 RISING USE OF PEPTIDE BIOMARKERS TO SUPPORT GROWTH
- 12.5 ACADEMIC & RESEARCH INSTITUTES
- 12.5.1 GROWING FOCUS ON DRUG DESIGN, VACCINE DEVELOPMENT, AND CANCER RESEARCH TO BOOST MARKET
- 12.6 CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS
- 12.6.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO FACILITATE GROWTH
13 PEPTIDE SYNTHESIS MARKET, BY REGION
- 13.1 INTRODUCTION
- 13.2 NORTH AMERICA
- 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 13.2.2 US
- 13.2.2.1 Well-developed healthcare and research infrastructure to aid growth
- 13.2.3 CANADA
- 13.2.3.1 Increasing government funding for advanced drugs to amplify growth
- 13.3 EUROPE
- 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 13.3.2 GERMANY
- 13.3.2.1 Germany to hold largest market share in Europe
- 13.3.3 UK
- 13.3.3.1 Increasing peptide synthesis research to contribute to growth
- 13.3.4 FRANCE
- 13.3.4.1 Favorable government initiatives to augment growth
- 13.3.5 ITALY
- 13.3.5.1 Growing public and private sector investments to propel market
- 13.3.6 SPAIN
- 13.3.6.1 Rising focus on advanced therapies to expedite growth
- 13.3.7 REST OF EUROPE
- 13.4 ASIA PACIFIC
- 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 13.4.2 CHINA
- 13.4.2.1 Expanding biopharma sector to advance growth
- 13.4.3 JAPAN
- 13.4.3.1 Growing geriatric population to fuel market
- 13.4.4 INDIA
- 13.4.4.1 Increasing investments and developments in biotechnology to favor growth
- 13.4.5 SOUTH KOREA
- 13.4.5.1 Booming biotechnology sector to amplify growth
- 13.4.6 AUSTRALIA
- 13.4.6.1 Increasing government funding and initiatives to augment growth
- 13.4.7 REST OF ASIA PACIFIC
- 13.5 LATIN AMERICA
- 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 13.5.2 BRAZIL
- 13.5.2.1 Growing interest in peptide-based drugs to fuel market
- 13.5.3 MEXICO
- 13.5.3.1 Increasing initiatives for stem cell research and regenerative medicine projects to foster growth
- 13.5.4 REST OF LATIN AMERICA
- 13.6 MIDDLE EAST
- 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 13.6.2 GCC COUNTRIES
- 13.6.2.1 Saudi Arabia
- 13.6.2.1.1 Increasing government-backed investments for infrastructure to aid growth
- 13.6.2.2 UAE
- 13.6.2.2.1 High prevalence of diabetes and cardiovascular diseases to augment growth
- 13.6.2.3 Rest of GCC Countries
- 13.6.3 REST OF MIDDLE EAST
- 13.7 AFRICA
- 13.7.1 INCREASING INVESTMENTS IN PHARMACEUTICAL INFRASTRUCTURE AND LIFE SCIENCE INNOVATIONS TO BOOST MARKET
- 13.7.2 MACROECONOMIC OUTLOOK FOR AFRICA
14 COMPETITIVE LANDSCAPE
- 14.1 OVERVIEW
- 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021-2025
- 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PEPTIDE SYNTHESIS MARKET
- 14.3 REVENUE ANALYSIS, 2019-2023
- 14.4 MARKET SHARE ANALYSIS, 2023
- 14.5 COMPANY VALUATION AND FINANCIAL METRICS
- 14.5.1 COMPANY VALUATION
- 14.5.2 FINANCIAL METRICS
- 14.6 BRAND/PRODUCT COMPARISON
- 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 14.7.1 STARS
- 14.7.2 EMERGING LEADERS
- 14.7.3 PERVASIVE PLAYERS
- 14.7.4 PARTICIPANTS
- 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
- 14.7.5.1 Company footprint
- 14.7.5.2 Region footprint
- 14.7.5.3 Offering footprint
- 14.7.5.4 Technique footprint
- 14.7.5.5 Application footprint
- 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 14.8.1 PROGRESSIVE COMPANIES
- 14.8.2 RESPONSIVE COMPANIES
- 14.8.3 DYNAMIC COMPANIES
- 14.8.4 STARTING BLOCKS
- 14.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
- 14.8.5.1 Detailed list of key startups/SMEs
- 14.8.5.2 Competitive benchmarking of startups/SMEs
- 14.9 COMPETITIVE SCENARIO
- 14.9.1 PRODUCT LAUNCHES
- 14.9.2 DEALS
- 14.9.3 EXPANSIONS
15 COMPANY PROFILES
- 15.1 KEY PLAYERS
- 15.1.1 THERMO FISHER SCIENTIFIC INC.
- 15.1.1.1 Business overview
- 15.1.1.2 Products/Services offered
- 15.1.1.3 Recent developments
- 15.1.1.3.1 Product launches
- 15.1.1.4 MnM view
- 15.1.1.4.1 Key strengths
- 15.1.1.4.2 Strategic choices
- 15.1.1.4.3 Weaknesses and competitive threats
- 15.1.2 MERCK KGAA
- 15.1.2.1 Business overview
- 15.1.2.2 Products/Services offered
- 15.1.2.3 MnM view
- 15.1.2.3.1 Key strengths
- 15.1.2.3.2 Strategic choices
- 15.1.2.3.3 Weaknesses and competitive threats
- 15.1.3 AGILENT TECHNOLOGIES, INC.
- 15.1.3.1 Business overview
- 15.1.3.2 Products/Services offered
- 15.1.3.3 MnM view
- 15.1.3.3.1 Key strengths
- 15.1.3.3.2 Strategic choices
- 15.1.3.3.3 Weaknesses and competitive threats
- 15.1.4 GENSCRIPT
- 15.1.4.1 Business overview
- 15.1.4.2 Products/Services offered
- 15.1.4.3 Recent developments
- 15.1.4.4 MnM view
- 15.1.4.4.1 Key strengths
- 15.1.4.4.2 Strategic choices
- 15.1.4.4.3 Weaknesses and competitive threats
- 15.1.5 KANEKA CORPORATION
- 15.1.5.1 Business overview
- 15.1.5.2 Products/Services offered
- 15.1.5.3 Recent developments
- 15.1.5.4 MnM view
- 15.1.5.4.1 Key strengths
- 15.1.5.4.2 Strategic choices
- 15.1.5.4.3 Weaknesses and competitive threats
- 15.1.6 BACHEM
- 15.1.6.1 Business overview
- 15.1.6.2 Products/Services offered
- 15.1.6.3 Recent developments
- 15.1.7 SYNGENE INTERNATIONAL LIMITED
- 15.1.7.1 Business overview
- 15.1.7.2 Products/Services offered
- 15.1.8 MESA LABS, INC.
- 15.1.8.1 Business overview
- 15.1.8.2 Products/Services offered
- 15.1.8.3 Recent developments
- 15.1.8.3.1 Product launches
- 15.1.8.3.2 Deals
- 15.1.9 BIOTAGE
- 15.1.9.1 Business overview
- 15.1.9.2 Products/Services offered
- 15.1.10 CEM CORPORATION
- 15.1.10.1 Business overview
- 15.1.10.2 Products/Services offered
- 15.1.10.3 Recent developments
- 15.1.10.3.1 Product launches
- 15.1.10.3.2 Deals
- 15.1.11 DALTON PHARMA SERVICES
- 15.1.11.1 Business overview
- 15.1.11.2 Products/Services offered
- 15.1.12 BIO-SYNTHESIS INC.
- 15.1.12.1 Business overview
- 15.1.12.2 Products/Services offered
- 15.1.13 CSBIO
- 15.1.13.1 Business overview
- 15.1.13.2 Products/Services offered
- 15.1.14 PROTEOGENIX
- 15.1.14.1 Business overview
- 15.1.14.2 Products/Services offered
- 15.1.15 INNOVAGEN AB
- 15.1.15.1 Business overview
- 15.1.15.2 Products/Services offered
- 15.1.16 BIOSYNTH
- 15.1.16.1 Business overview
- 15.1.16.2 Products/Services offered
- 15.2 OTHER PLAYERS
- 15.2.1 AURIGENE PHARMACEUTICAL SERVICES LTD.
- 15.2.2 CORDENPHARMA
- 15.2.3 JPT PEPTIDE TECHNOLOGIES
- 15.2.4 PUROLITE
- 15.2.5 BIOMATIK
- 15.2.6 CPC SCIENTIFIC INC.
- 15.2.7 ADVANCED CHEMTECH, INC.
- 15.2.8 AMBIOPHARM INC.
- 15.2.9 LUXEMBOURG BIO TECHNOLOGIES
- 15.2.10 AAPPTEC
- 15.2.11 ANYGEN
- 15.2.12 CHEMPEP
- 15.2.13 PROTEOGENIX
16 APPENDIX
- 16.1 DISCUSSION GUIDE
- 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 16.3 CUSTOMIZATION OPTIONS
- 16.4 RELATED REPORTS
- 16.5 AUTHOR DETAILS
